Vivo Capital VIII, LLC

13D and 13G Filings

Issuer	Symbol	CUSIP	% of Class	Shares	Form	Filed
Sinovac Biotech Ltd. 13D/A Amendment 6 SVA · P8696W104	SVA	P8696W104	6.3%	4,541,764	13D/A Amendment 6	7/11/2025 Event 7/11/2025
Vivo Capital VIII, LLC			1.9%	1,361,236
Vivo Capital IX, LLC			6.3%	4,541,764
Sinovac Biotech Ltd. 13D/A Amendment 5 SVA · P8696W104	SVA	P8696W104	6.3%	4,541,764	13D/A Amendment 5	6/13/2025 Event 6/11/2025
Vivo Capital VIII, LLC			1.9%	1,361,236
Vivo Capital IX, LLC			6.3%	4,541,764
Sinovac Biotech Ltd. 13D/A Amendment 4 SVA · P8696W104	SVA	P8696W104	6.3%	4,539,456	13D/A Amendment 4	4/24/2025 Event 4/23/2025
Vivo Capital VIII, LLC			1.9%	1,360,544
Vivo Capital IX, LLC			6.3%	4,539,456

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.